These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 36266040)
1. Ongoing Controversies in Esophageal Cancer II: Gastrectomy versus Esophagectomy for Siewert Type II Esophageal Adenocarcinoma. Devaud N; Carroll P Thorac Surg Clin; 2022 Nov; 32(4):553-563. PubMed ID: 36266040 [TBL] [Abstract][Full Text] [Related]
2. Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer. Haverkamp L; Seesing MF; Ruurda JP; Boone J; V Hillegersberg R Dis Esophagus; 2017 Jan; 30(1):1-7. PubMed ID: 27001442 [TBL] [Abstract][Full Text] [Related]
3. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors. Mine S; Kurokawa Y; Takeuchi H; Kishi K; Ito Y; Ohi M; Matsuda T; Hamakawa T; Hasegawa S; Yoshikawa T; Hiki N Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995 [TBL] [Abstract][Full Text] [Related]
4. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery]. Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535 [TBL] [Abstract][Full Text] [Related]
5. The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II. Leers JM; Knepper L; van der Veen A; Schröder W; Fuchs H; Schiller P; Hellmich M; Zettelmeyer U; Brosens LAA; Quaas A; Ruurda JP; van Hillegersberg R; Bruns CJ BMC Cancer; 2020 Aug; 20(1):781. PubMed ID: 32819399 [TBL] [Abstract][Full Text] [Related]
6. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction]. Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538 [TBL] [Abstract][Full Text] [Related]
7. Surgical approach to advanced Siewert II cancer: beyond the borders? The West Side. Hölscher AH; Bollschweiler E; Fetzner UK; Babic B Updates Surg; 2023 Feb; 75(2):329-333. PubMed ID: 36001282 [TBL] [Abstract][Full Text] [Related]
8. Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option. Hu C; Zhu HT; Xu ZY; Yu JF; Du YA; Huang L; Yu PF; Wang LJ; Cheng XD J Int Med Res; 2019 Jan; 47(1):398-410. PubMed ID: 30296865 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of lower perigastric lymph nodes dissection in Siewert type II/III adenocarcinoma of esophagogastric junction: a retrospective propensity score matched study. Li ZL; Zhao LY; Zhang WH; Liu K; Pang HY; Chen XL; Chen XZ; Yang K; Hu JK Langenbecks Arch Surg; 2022 May; 407(3):985-998. PubMed ID: 34792614 [TBL] [Abstract][Full Text] [Related]
10. [Surgical strategy for adenocarcinoma of esophagogastric junction]. Lu Y; Zhang K; Chen L Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):107-111. PubMed ID: 30799532 [TBL] [Abstract][Full Text] [Related]
11. The Impact of D2 Versus D1 Lymphadenectomy in Siewert II Gastroesophageal Junction (GEJ) Cancer. Alcasid NJ; Fink D; Banks KC; Susai CJ; Barnes K; Wile R; Sun A; Patel A; Ashiku S; Velotta JB Ann Surg Oncol; 2024 Nov; 31(12):8148-8156. PubMed ID: 39080133 [TBL] [Abstract][Full Text] [Related]
12. Esophagectomy or Total Gastrectomy for Siewert 2 Gastroesophageal Junction (GEJ) Adenocarcinoma? A Registry-Based Analysis. Kamarajah SK; Phillips AW; Griffiths EA; Ferri L; Hofstetter WL; Markar SR Ann Surg Oncol; 2021 Dec; 28(13):8485-8494. PubMed ID: 34255246 [TBL] [Abstract][Full Text] [Related]
13. Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type II adenocarcinoma of the esophagogastric junction. Sugita S; Kinoshita T; Kaito A; Watanabe M; Sunagawa H Surg Endosc; 2018 Jan; 32(1):383-390. PubMed ID: 28656339 [TBL] [Abstract][Full Text] [Related]
14. [Surgical treatment strategies for Siewert type II adenocarcinoma of the esophagogastric junction]. Yan Q; Lyu ZJ; Zheng JB; Li Y Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):1008-1012. PubMed ID: 33054000 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of Siewert type II adenocarcinoma of the esophagogastric junction: the perspectives from thoracic surgery]. Li ZY; Gu YM; Wang WP; Chen LQ Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Feb; 25(2):109-113. PubMed ID: 35176820 [TBL] [Abstract][Full Text] [Related]
16. Transthoracic single-port-assisted laparoscopic gastrectomy versus laparoscopic transhiatal approach for Siewert type II adenocarcinoma of the esophagogastric junction: a single-center retrospective study. Li J; Xiong W; Ou H; Yang T; Jiang S; Huang H; Zheng Y; Luo L; Peng X; Wang W Surg Endosc; 2024 Apr; 38(4):1986-1994. PubMed ID: 38381159 [TBL] [Abstract][Full Text] [Related]
17. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Rüdiger Siewert J; Feith M; Werner M; Stein HJ Ann Surg; 2000 Sep; 232(3):353-61. PubMed ID: 10973385 [TBL] [Abstract][Full Text] [Related]
18. Optimal surgery for esophagogastric junctional cancer. Hayashi T; Yoshikawa T Langenbecks Arch Surg; 2022 Jun; 407(4):1399-1407. PubMed ID: 34786603 [TBL] [Abstract][Full Text] [Related]
19. [Modern diagnostics and stage-oriented surgery: therapy of adenocarcinoma of the esophagogastric junction]. Hölscher AH; Fetzner UK Chirurg; 2012 Aug; 83(8):702-8, 710-1. PubMed ID: 22878576 [TBL] [Abstract][Full Text] [Related]
20. Esophagogastric junction adenocarcinomas: individualization of resection with special considerations for Siewert type II, and Nishi types EG, E=G and GE cancers. Hölscher AH; Law S Gastric Cancer; 2020 Jan; 23(1):3-9. PubMed ID: 31691875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]